Liu Tom J, Lin Mong-Wei, Hsieh Min-Shu, Kao Ming-Wei, Chen Ke-Cheng, Chang Chin-Chih, Kuo Shuenn-Wen, Huang Pei-Ming, Hsu Hsao-Hsun, Chen Jin-Shing, Lai Hong-Shiee, Lee Jang-Ming
Department of Surgery, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan, ROC.
Ann Surg Oncol. 2014 Jan;21(1):322-8. doi: 10.1245/s10434-013-3228-7. Epub 2013 Aug 28.
For thymoma, the feasibility of resection via video-assisted thoracoscopic surgery (VATS) remains controversial. The objective of our study was to compare the outcomes of VATS and transsternal thymectomy in order to evaluate the efficacy of the VATS method for treatment of early stage thymoma.
This study is a retrospective study of 120 patients who underwent thymectomy of early stage thymoma (Masaoka stage I and II) in a single medical center from 1991 to 2010. Of these patients, 76 patients underwent VATS thymectomy (VATS group) and 44 patients underwent the conventional transsternal approach (sternotomy group). We applied the Kaplan-Meier method to estimate overall survival (OS), recurrence-free survival (RFS), and time to tumor recurrence (TTR) of these two groups.
The mean follow-up time was 61.9 months in the VATS group and 69.7 months in the sternotomy group. There was no surgery-related mortality or major complication. The VATS group had smaller specimen size (p < 0.05) and tumor size (p < 0.01), shorter length of stay (LOS) in the hospital (p < 0.01), and shorter duration of chest tube drainage (p < 0.05) than the sternotomy group. There were no significant differences between the two groups for OS, RFS, and TTR.
In early stage thymoma, VATS thymectomy associated with shorter hospital LOS and shorter duration of pleural drainage compared with the conventional transsternal approach. Otherwise, the two approaches had similar oncologic outcomes during the mean 60-month follow-up period.
对于胸腺瘤,通过电视辅助胸腔镜手术(VATS)进行切除的可行性仍存在争议。我们研究的目的是比较VATS和经胸骨胸腺切除术的结果,以评估VATS方法治疗早期胸腺瘤的疗效。
本研究是一项回顾性研究,对1991年至2010年在单个医疗中心接受早期胸腺瘤(Masaoka I期和II期)胸腺切除术的120例患者进行研究。在这些患者中,76例接受了VATS胸腺切除术(VATS组),44例接受了传统的经胸骨入路(胸骨切开术组)。我们应用Kaplan-Meier方法估计这两组患者的总生存期(OS)、无复发生存期(RFS)和肿瘤复发时间(TTR)。
VATS组的平均随访时间为61.9个月,胸骨切开术组为69.7个月。没有手术相关的死亡或重大并发症。与胸骨切开术组相比,VATS组的标本尺寸(p < 0.05)和肿瘤大小(p < 0.01)更小,住院时间(LOS)更短(p < 0.01),胸腔引流管留置时间更短(p < 0.05)。两组在OS、RFS和TTR方面没有显著差异。
在早期胸腺瘤中,与传统的经胸骨入路相比,VATS胸腺切除术的住院时间和胸腔引流时间更短。否则,在平均60个月的随访期内,这两种方法的肿瘤学结果相似。